Archives of Gynecology and Obstetrics

, Volume 297, Issue 4, pp 859–870 | Cite as

Unilateral or bilateral laparoscopic ovarian drilling in polycystic ovary syndrome: a meta-analysis of randomized trials

Review
  • 146 Downloads

Abstract

Purpose

This systematic review and meta-analysis aimed to compare the effectiveness of unilateral vs. bilateral laparoscopic ovarian drilling (ULOD vs. BLOD) for improving fertility outcomes in infertile women with clomiphene-resistant polycystic ovary syndrome (PCOS) as well as its effect on ovarian reserve.

Methods

Searches were conducted on PubMed, ScienceDirect, ClinicalTrials.gov, and CENTRAL databases from January 1984 to January 2017. Only randomized trials comparing ULOD with BLOD were included. The PRISMA Statement was followed. Main outcomes were ovulation and clinical pregnancy rates per woman randomized. Secondary outcomes were; live birth and miscarriage rates as well as postoperative serum anti-mullerian hormone (AMH) concentration and antral follicle count (AFC). Quality assessment was performed by the Cochrane Collaboration risk of bias tool.

Results

Eight eligible trials (484 women) were analyzed. No significant difference was found in rates of ovulation (OR 0.73; 95% CI 0.47–1.11), clinical pregnancy (OR 0.56; 95% CI 0.22–1.41), live birth (OR 0.77; 95% CI 0.28–2.10), or miscarriage (OR 0.90; 95% CI 0.33–2.84) when ULOD was compared with BLOD. The reduction in AMH was comparable between the two procedures (MD 0.64 ng/ml; 95% CI − 0.08 to 1.36). A significantly higher AFC at 6-month follow-up was found with dose-adjusted ULOD (MD 2.20; 95% CI 1.01–3.39).

Conclusions

After carefully weighing up the well-known benefits of BLOD against a potential risk to ovarian reserve, clinicians could be advised to offer the fixed-dose ULOD to their infertile patients with clomiphene-resistant PCOS. This is concordant with the “primum non nocere” principal if LOD will be envisaged.

Keywords

Unilateral ovarian drilling Unilateral ovarian diathermy Polycystic ovary syndrome PCOS Ovulation and pregnancy 

Notes

Author contributions

All authors contributed to the development of the manuscript and all authors consented to its submission and publication. Specific contributions are as follows; HAH: design and institution of the study protocol, collection, and analysis of data, drafting, review, and final preparation of the article, and approval of the final version. OF: design and institution of the study protocol, collection and analysis of data, drafting, review and final preparation of the article, and approval of the final version. MELR: institution of the study protocol, analysis of data, review, and approval of the final version.

Compliance with ethical standards

Funding

No funding

Conflict of interest

We declare that we have no conflict of interest.

Ethical approval

Not applicable.

Supplementary material

404_2018_4680_MOESM1_ESM.doc (32 kb)
Supplementary material 1 (DOC 32 kb)
404_2018_4680_MOESM2_ESM.doc (90 kb)
Supplementary material 2 (DOC 90 kb)

References

  1. 1.
    ESE, PCOS Special Interest Group (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171:1–29CrossRefGoogle Scholar
  2. 2.
    ESHRE Capri Workshop Group (2012) Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update 18:586–599CrossRefGoogle Scholar
  3. 3.
    Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25Google Scholar
  4. 4.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89:505–522CrossRefGoogle Scholar
  5. 5.
    The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group (2012) Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Fertil Steril 97:28–38CrossRefGoogle Scholar
  6. 6.
    Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H (2012) Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 27:3067–3073CrossRefPubMedGoogle Scholar
  7. 7.
    Brown J, Farquhar C (2016) Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev 12:CD002249PubMedGoogle Scholar
  8. 8.
    Abu Hashim H (2012) Clomiphene citrate alternatives for the initial management of polycystic ovary syndrome: an evidence-based approach. Arch Gynecol Obstet 285:1737–1745CrossRefPubMedGoogle Scholar
  9. 9.
    National collaborating centre for women’s and children’s health/national institute for clinical excellence (2013) Fertility: assessment and treatment for people with fertility problems. In: Clinical guideline no. 156. RCOG Press, London. https://www.nice.org.uk/guidance/cg156
  10. 10.
    GjÖnnaess H (1984) Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil Steril 41:20–25CrossRefPubMedGoogle Scholar
  11. 11.
    Abu Hashim H, Al-Inany H, De Vos M, Tournaye H (2013) Three decades after Gjönnaess’s laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach. Arch Gynecol Obstet 288:409–422CrossRefPubMedGoogle Scholar
  12. 12.
    Li RH, Ng EH (2012) Management of anovulatory infertility. Best Pract Res Clin Obstet Gynaecol 26:757–768CrossRefPubMedGoogle Scholar
  13. 13.
    Abu Hashim H (2015) Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome: an evidence-based approach. Arch Gynecol Obstet 291:11–18CrossRefPubMedGoogle Scholar
  14. 14.
    Mercorio F, Mercorio A, Di Spiezio Sardo A, Barba GV, Pellicano M, Nappi C (2008) Evaluation of ovarian adhesion formation after laparoscopic ovarian drilling by second-look minilaparoscopy. Fertil Steril 89:1229–1233CrossRefPubMedGoogle Scholar
  15. 15.
    Api M (2009) Is ovarian reserve diminished after laparoscopic ovarian drilling? Gynecol Endocrinol 25:159–165CrossRefPubMedGoogle Scholar
  16. 16.
    Balen AH, Jacobs HS (1994) A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome. Fertil Steril 62:921–925CrossRefPubMedGoogle Scholar
  17. 17.
    Al-Mizyen E, Grudzinskas JG (2007) Ultrasonographic observations following unilateral and bilateral laparoscopic ovarian diathermy in infertile women with clomiphene citrate resistant polycystic ovarian syndrome (PCOS). Middle East Fertil Soc J 12:207–212Google Scholar
  18. 18.
    Youssef H, Atallah MM (2007) Unilateral ovarian drilling in polycystic ovarian syndrome: a prospective randomized study. Reprod Biomed Online 15:457–462CrossRefPubMedGoogle Scholar
  19. 19.
    Roy KK, Baruah J, Moda N, Kumar S (2009) Evaluation of unilateral versus bilateral ovarian drilling in clomiphene citrate resistant cases of polycystic ovarian syndrome. Arch Gynecol Obstet 280:573–578CrossRefPubMedGoogle Scholar
  20. 20.
    Sunj M, Canic T, Baldani DP, Tandara M, Jeroncic A, Palada I (2013) Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome? Hum Reprod 28:2417–2424CrossRefPubMedGoogle Scholar
  21. 21.
    Sunj M, Kasum M, Canic T et al (2014) Assessment of ovarian reserve after unilateral diathermy with thermal doses adjusted to ovarian volume. Gynecol Endocrinol 30:785–788CrossRefPubMedGoogle Scholar
  22. 22.
    Rezk M, Sayyed T, Saleh S (2016) Impact of unilateral versus bilateral laparoscopic ovarian drilling on ovarian reserve and pregnancy rate: a randomized clinical trial. Gynecol Endocrinol 32:399–402CrossRefPubMedGoogle Scholar
  23. 23.
    Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Zawadski JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GE (eds) Polycystic ovary syndrome; current issues in endocrinology and metabolism. Blackwell Scientific Inc, Boston, pp 377–384Google Scholar
  25. 25.
    Azziz R, Carmina E, Dewailly D et al (2009) Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS Society. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456–488CrossRefPubMedGoogle Scholar
  26. 26.
    Higgins JPT, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions, Version 5.1.0 (updated March 2011). The Cochrane Collaboration. http://handbook.cochrane.org
  27. 27.
    Jamal HS (2000) Bilateral or unilateral KTP laser ovarian drilling in polycystic ovarian disease. Ann Saudi Med 20:165–167CrossRefPubMedGoogle Scholar
  28. 28.
    Zahiri Sorouri Z, Sharami SH, Tahersima Z, Salamat F (2015) Comparison between unilateral and bilateral ovarian drilling in clomiphene citrate resistance polycystic ovary syndrome patients: a randomized clinical trial of efficacy. Int J Fertil Steril 9:9–16PubMedPubMedCentralGoogle Scholar
  29. 29.
    Nasr A (2013) Impact of unilateral versus bilateral laparoscopic ovarian drilling on ovarian reserve in clomiphene citrate-resistant PCOS women. Fertil Steril 100(Suppl):S114CrossRefGoogle Scholar
  30. 30.
    Broer SL, Broekmans FJ, Laven JS, Fauser BC (2014) Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update 20:688–701CrossRefPubMedGoogle Scholar
  31. 31.
    Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R (2015) Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study. Fertil Steril 103:537–541CrossRefPubMedGoogle Scholar
  32. 32.
    Pellatt L, Hanna L, Brincat M et al (2007) Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 92:240–245CrossRefPubMedGoogle Scholar
  33. 33.
    Farquhar C, Brown J, Marjoribanks J (2012) Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 6:CD001122Google Scholar
  34. 34.
    Sharma M, Kriplani A, Agarwal N (2006) Laparoscopic bipolar versus unipolar ovarian drilling in infertile women with resistant polycystic ovarian syndrome: a pilot study. J Gynecol Surg 22:105–111CrossRefGoogle Scholar
  35. 35.
    Al-Mizyen E, Grudzinskas JG (2000) Unilateral versus bilateral laparoscopic ovarian diathermy in the management of infertile women with polycystic ovarian syndrome. In: Abstracts of the 16th annual meeting of the ESHRE, p 262Google Scholar
  36. 36.
    Baghdadi LR, Abu Hashim H, Amer SA et al (2012) Impact of obesity on reproductive outcomes after ovarian ablative therapy in PCOS: a collaborative meta-analysis. Reprod BioMed Online 25:227–241CrossRefPubMedGoogle Scholar
  37. 37.
    Chiofalo B, Laganà AS, Palmara V et al (2017) Fasting as possible complementary approach for polycystic ovary syndrome: hope or hype? Med Hypotheses 105:1–3CrossRefPubMedGoogle Scholar
  38. 38.
    Abu Hashim H (2013) Alternatives to laparoscopic ovarian drilling for ovulation induction in clomiphene resistant women with polycystic ovary syndrome: an evidence based approach. In: De Lange K, Deguire E (eds) Ovulation: detection, signs/symptoms and outcomes. Nova Science Publishers Inc., Hauppauge, pp 97–115Google Scholar
  39. 39.
    Abu Hashim H, Foda O, Ghayaty E (2015) Combined metformin-clomiphene in clomiphene-resistant polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand 94:921–930CrossRefPubMedGoogle Scholar
  40. 40.
    Abu Hashim H (2016) Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence? Reprod Biomed Online 32:44–53CrossRefPubMedGoogle Scholar
  41. 41.
    Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G (1999) Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 340:1314–1320CrossRefPubMedGoogle Scholar
  42. 42.
    Pizzo A, Laganà AS, Barbaro L (2014) Comparison between effects of myoinositol and d-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecol Endocrinol 30:205–208CrossRefPubMedGoogle Scholar
  43. 43.
    Laganà AS, Barbaro L, Pizzo A (2015) Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-chiro-inositol. Arch Gynecol Obstet 291:1181–1186CrossRefPubMedGoogle Scholar
  44. 44.
    Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J (2017) Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect 6:647–658CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Laganà AS, Rossetti P, Sapia F et al (2017) Evidence-based and patient-oriented inositol treatment in polycystic ovary syndrome: changing the perspective of the disease. Int J Endocrinol Metab 22(15):e43695Google Scholar
  46. 46.
    Facchinetti F, Bizzarri M, Benvenga S et al (2015) Results from the international consensus conference on myoinositol and d-chiro-inositol in obstetrics and gynecology: the link between metabolic syndrome and PCOS. Eur J Obstet Gynecol Reprod Biol 195:72–76CrossRefPubMedGoogle Scholar
  47. 47.
    Fernandez H, Alby JD, Gervaise A et al (2001) Operative transvaginal hydrolaparoscopy for treatment of polycystic ovary syndrome: a new minimally invasive surgery. Fertil Steril 75:607–611CrossRefPubMedGoogle Scholar
  48. 48.
    Casa A, Sesti F, Marziali M, Gulemì L, Piccione E (2003) Transvaginal hydrolaparoscopic ovarian drilling using bipolar electrosurgery to treat anovulatory women with polycystic ovary syndrome. J Am Assoc Gynecol Laparosc 10:219–222CrossRefPubMedGoogle Scholar
  49. 49.
    Fernandez H, Watrelot A, Alby JD et al (2004) Fertility after ovarian drilling by transvaginal fertiloscopy for treatment of polycystic ovary syndrome. J Am Assoc Gynecol Laparosc 11:374–378CrossRefPubMedGoogle Scholar
  50. 50.
    Gordts S, Gordts S, Puttemans P et al (2009) Transvaginal hydrolaparoscopy in the treatment of polycystic ovary syndrome. Fertil Steril 91:2520–2526CrossRefPubMedGoogle Scholar
  51. 51.
    Poujade O, Gervaise A, Faivre E, Deffieux X, Fernandez H (2011) Surgical management of infertility due to polycystic ovarian syndrome after failure of medical management. Eur J Obstet Gynecol Reprod Biol 158:242–247CrossRefPubMedGoogle Scholar
  52. 52.
    Giampaolino P, De Rosa N, Della Corte L et al (2018) Operative transvaginal hydrolaparoscopy improve ovulation rate after clomiphene failure in polycystic ovary syndrome. Gynecol Endocrinol 34:32–35CrossRefPubMedGoogle Scholar
  53. 53.
    Giampaolino P, Morra I, De Rosa N et al (2017) Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case–control study. Gynecol Endocrinol 33:690–693CrossRefPubMedGoogle Scholar
  54. 54.
    Giampaolino P, Morra I, Della Corte L et al (2017) Serum anti-Mullerian hormone levels after ovarian drilling for the second-line treatment of polycystic ovary syndrome: a pilot-randomized study comparing laparoscopy and transvaginal hydrolaparoscopy. Gynecol Endocrinol 33:26–29CrossRefPubMedGoogle Scholar
  55. 55.
    Giampaolino P, Morra I, Tommaselli GA, Di Carlo C, Nappi C, Bifulco G (2016) Post-operative ovarian adhesion formation after ovarian drilling: a randomized study comparing conventional laparoscopy and transvaginal hydrolaparoscopy. Arch Gynecol Obstet 294:791–796CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, Faculty of MedicineMansoura UniversityMansouraEgypt
  2. 2.Endocrinology Unit, Department of Internal MedicineMansoura UniversityMansouraEgypt
  3. 3.Department of Diagnostic Radiology, Faculty of MedicineMansoura UniversityMansouraEgypt

Personalised recommendations